Churchill Capital VII announced that it plans to transfer its listing from the New York Stock Exchange to the Nasdaq.
Churchill VII expects that listing and trading on the NYSE will end at market close Feb. 2, with trading set to begin Feb. 5 on the Nasdaq. The SPAC’s shares, units and warrants will trade under the respective ticker symbols CVII, CVIIU and CVIIW.
Churchill VII has a merger agreement with CorpAcq Holdings Limited. The deal has a pro forma enterprise value of approximately $1.58 billion. If the deal is approved, upon closing CorpAcq will be a publicly traded corporate compounder with a portfolio of 42 businesses.
The transactions are expected to close in early 2024. Read more.
